Clinical

St. Jude received the hospital’s first expanded access designation from the FDA for use of PET scans with [11C]Methionine a tracer that makes imaging results clearer.

The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.

A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.

Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.

What lessons can be learned from the remarkable success of SAFER Ukraine?

Interim results point to enduring immune function following gene therapy for Infants with ‘bubble boy’ disease

May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.

What are the potential psychological and emotional risks and rewards for parents who serve as their children’s bone marrow donors?

St. Jude researchers looked at burnout and perceived work demands among St. Jude physicians and found that emotional exhaustion and time demands are key factors in a problem that affects both provider and patient.

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.